| Logo Mark Takeda Pharmaceuticals International AG
98259188 07 Nov 2023 | on 10 Dec 2024
| Pharmaceutical preparations for the treatment of neurological diseases Class 005 Class 005 Pharmaceutical Products The mark consists of a solid orange circle surrounded by a broken yellow circle design, which is interrupted by a green circle with an open center on the top left side. The white in the drawing, including in the center of the green circle, represents background and is not part of the mark. | | | MYADMIA Takeda Pharmaceuticals International AG
97587826 12 Sep 2022 | on 27 Aug 2024
| Pharmaceutical preparations, namely, preparations for enzyme replaceme... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, preparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy | | | ADZYNMA Takeda Pharmaceuticals International AG
97587783 12 Sep 2022 | on 16 Apr 2024
| Pharmaceutical preparations, namely, enzyme replacement therapy for th... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, enzyme replacement therapy for thrombotic disorders | | | MYAMDIA Takeda Pharmaceuticals International AG
97587797 12 Sep 2022 | on 09 Apr 2024
| Pharmaceutical preparations, namely, preparations for enzyme replaceme... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, preparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy | | | Logo Mark Takeda Pharmaceuticals International AG
97932287 11 May 2023 | on 26 Mar 2024
| Pharmaceutical preparations for the treatment of neurological diseases Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. | | | Logo Mark Takeda Pharmaceuticals International AG
97836574 13 Mar 2023 | on 21 Nov 2023
| Pharmaceutical preparations, namely, preparations for enzyme replaceme... Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. | | | Logo Mark Takeda Pharmaceuticals International AG
97403759 10 May 2022 | on 27 Jun 2023
| Pharmaceutical preparations for the treatment of the consequences of g... Class 005 Class 005 Pharmaceutical Products The mark consists of a spiral ribbon design. | | | BEYREZA Takeda Pharmaceuticals International AG
97333954 28 Mar 2022 | on 23 May 2023
| Pharmaceutical products for use in the field of neuroscience, namely, ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome | | | SOZEMPA Takeda Pharmaceuticals International AG
97333970 28 Mar 2022 | on 23 May 2023
| Pharmaceutical products for use in the field of neuroscience, namely, ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome | | | BEYRIZO Takeda Pharmaceuticals International AG
97333961 28 Mar 2022 | on 23 May 2023
| Pharmaceutical products for use in the field of neuroscience, namely, ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome | | 
